Irafamdastat
Irafamdastat (BMS-986368) (Example 74) is a FAAH and MAGL inhibitor, with IC50s ≤ 100 nM (human FAAH) and 100 nM-1 μM (human MAGL) respectively. Irafamdastat has antiepileptic effect[1][2].
Product Specifications
CAS Number
2244136-58-9
Product Name Alternative
BMS-986368; CC-97489; ABX-1772
UNSPSC
12352005
Target
FAAH; MAGL
Related Pathways
Metabolic Enzyme/Protease; Neuronal Signaling
Field of Research
Neurological Disease
Purity
98.07
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
NC(C1=CC(OC(N2[C@@H](CN(CC2)CC3=CC(OC(F)(F)F)=CC=C3)C)=O)=CN=C1)=O
Molecular Formula
C20H21F3N4O4
Molecular Weight
438.40
References & Citations
[1]Cheryl A. Grice, et al. Dual magl and faah inhibitors. Patent. US20180256566A1|[2]Tim Depmeier, et al. Carbamates with ortho-Substituted O-Phenyl Groups as Dual Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: Inhibitory Potency, Hydrolytic Stability, and QSAR Studies. 2025. ACS Medicinal Chemistry Letters.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC401778 20 µg
Sigma1 receptor (SIGMAR1) (NM_005866) Human Over-expression Lysate
Sign In for Pricing
View Details 
PKSH032285-01 10 µg
Recombinant Human Creatine Kinase, Muscle/CKM Protein (His Tag)
Sign In for Pricing
View Details PKSH032285-02 50 µg
Recombinant Human Creatine Kinase, Muscle/CKM Protein (His Tag)
Sign In for Pricing
View Details 